Drug · DIN 02239653
ANDRODERM
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since April 14, 2022; first marketed December 19, 2000.
- Drug Identification Number (DIN)
- 02239653
- Company (DIN owner)
- Allergan IncMarkham, Ontario, Canada
- Schedule
- Controlled drugs (CDSA IV)
- Dosage form
- Patch
- Route
- Transdermal
- Therapeutic class (ATC)
- Testosterone G03BA03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TESTOSTERONE | 2.5 MG | 24 HOUR |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 28, 2018: NOC 20536New Drug Submission (NDS) · Manufacturer name change
- November 24, 2016: NOC 18712New Drug Submission (NDS) · Manufacturer name change
- January 29, 2015: NOC 16574New Drug Submission (NDS) · Merger - buyout
- October 16, 2007: NOC 9094New Drug Submission (NDS) · Manufacturer name change
- November 29, 2000: NOC 1525New Drug Submission (NDS)
- October 2, 2000: NOC 1526New Drug Submission (NDS)
- February 17, 1999: NOC 2085New Drug Submission (NDS)
Other DINs named ANDRODERM
- DIN 02245972 · Cancelled Post Market